Skip to content

Penumbra PEN Finance Lease, Principal Payments

Finance Lease, Principal Payments at other companies

Boston Scientific logo
Boston ScientificBSX
$0-100%

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's finance lease, principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's finance lease, principal payments?
Penumbra (PEN) reported finance lease, principal payments of $617K in Q1 2026.
How has Penumbra's finance lease, principal payments changed year-over-year?
Penumbra's finance lease, principal payments increased by 0.7% year-over-year, from $613K to $617K.
What is the long-term trend for Penumbra's finance lease, principal payments?
Over 4 years (2021 to 2025), Penumbra's finance lease, principal payments has grown at a 14.4% compound annual growth rate (CAGR), from $1.45M to $2.49M.